This year’s symposium will focus on “legal” substances that pose a significant health and safety threat to youth. Alcohol, marijuana, and prescription medications are increasingly being abused and the harm associated with this abuse is underappreciated. The variety of attitudes about these substances combined with the knowledge gap of current research based evidence complicates the picture.
The days 5 hour program will expand the participant’s knowledge base as well as provide useful insights into strategies and interventions on these issues confronting young people, as well as research and public policy that forms the foundation for the response to these problems.
The program will again combine nationally recognized experts with local expert presenters, utilizing both individual presentations followed by a panel discussion and question and answer period.
1. Describe local conditions related to substance abuse amongst youth in our community
2. Identify prevalence related to substance abuse in youth in particular groups of demographics such as the LGBT community and lower socioeconomic groups
3. Apply strategies to effectively communicate with young people about risks associated with substance abuse in a culture that sends mixed messages about alcohol, marijuana, and prescription medication
4. Describe the “Strategic Prevention Framework” project
5. Assess effectiveness of various initiatives related to youth and substance misuse currently implemented
6. Apply guidelines for effective interventions
7. Identify behavioral addictive conditions, classifications, and related neurobiology
8. Describe cellular and neural pathways involved in drug and/or alcohol cravings
9. Identify the role family and older peers play in both promoting and preventing substance abuse amongst youth
In an effort to go green, the speaker’s power point presentations will not be distributed at the event. Electronic versions of handouts and presentations will be made available for download online to all registered participants when available. Please review the materials and print those that you wish to have with you at the program and bring them with you.
This educational event is targeted toward Psychiatrists, Emergency Physicians, Pediatricians, and General Practitioners, but open to all physician specialties. It is also open to all other clinical / healthcare workers, as well as law enforcement, social workers, therapists, and other professionals who have an interest in the subject matter.
Thomas McLellan, PhD - Prescription Medication Focus
Dr. McLellan is the CEO and co-founder of the Treatment Research Institute (TRI) and an experienced substance abuse researcher. From 2009 to 2010, he was Science Advisor and Deputy Director of the White House Office of National Drug Control Policy (ONDCP), a congressionally confirmed Presidential appointment to help shape the nation’s public policy approach to illicit drug use. At ONDCP, McLellan worked on a broad range of drug issues, including formulation and implementation of the President’s National Drug Control Strategy and promotion of drug treatment through the broader revamping of the national health care system. Dr. McLellan has more than 35 years of experience in addiction treatment research. In 1992, he co-founded and led TRI (until his ONDCP appointment) to transform the way research is employed in the treatment of and policy making around substance use and abuse. In his career he has published over 400 articles and chapters on addiction research. From 2000-2009 he was Editor-in-Chief of the Journal of Substance Abuse Treatment, and he has also served on several other editorial boards of scientific journals. Dr. McLellan is the recipient of several distinguished awards including the Life Achievement Awards of the American and British Societies of Addiction Medicine (2001 & 2003); the Robert Wood Johnson Foundation Innovator Award (2005); and awards for Distinguished Contribution to Addiction Medicine from the Swedish (2002) and Italian (2002) Medical Associations. In the 1980s, with his colleagues from the Center for the Studies of Addiction at the University of Pennsylvania, Dr. McLellan introduced the Addiction Severity Index and, later, the Treatment Services Review. Both are among the most widely used assessment instruments in the world.
Jim Mosher, JD - Alcohol Focus
Mr. Mosher is a leading scholar in the field of alcohol policy and the law. He is recognized internationally for his groundbreaking work on policy approaches to the prevention of alcohol problems. His pioneering work spans three decades as a researcher, legal scholar, policy analyst, lecturer, trainer, community organizer, and advocate. He is the co-founder of the Marin Institute for the Prevention of Alcohol and Other Drug Problems, where he served as Executive Director and Director of Public Policy and Research from 1987 to 2000. He established the Center for the Study of Law and Enforcement Policy at the Pacific Institute for Research and Evaluation in 2001, serving as its director until March 2008. Today he is the Senior Policy Advisor at The CDM Group, Inc. and heads Alcohol Policy Consultations, a private consultancy group. Mr. Mosher is the recipient of the Leadership Award, Section on Alcohol, Tobacco, and Other Drugs, American Public Health Association and the Milton Terris Award for Distinguished Leadership in the Development and Implementation of Public Health Policy. He received his law degree from the University of California at Berkeley.
Timmen L. Cermak, MD - Marijuana Focus
Dr. Cermak studied philosophy as an undergraduate at Ohio Wesleyan University, before graduating from Case Western Reserve Medical School in 1972. After 2 years with the Indian Health Service, he entered his psychiatry residency at Stanford, where he assisted Dr. Stephanie Brown in creating the first therapy group for adult children of alcoholics. Following a post-doctoral fellowship in neurophysiology under Dr. Karl Pribram, he served as medical director of the alcohol inpatient unit at the San Francisco V.A. hospital from 1982-85. During this time he helped found the National Association for Children of Alcoholics (NACoA), serving first as president and then chairman of the board. He currently has private practice offices in San Francisco and Mill Valley, CA. Dr. Cermak is Board Certified in Psychiatry, with a Certificate of Added Qualification in Addiction Psychiatry. He is also certified by the American Society of Addiction Medicine (ASAM). He serves on the Executive Council of the California Society of Addiction Medicine (CSAM), chaired CSAM’s task force on medical marijuana and is editor of the society’s newsletter. He is currently President of CSAM and co-chairs the subcommittee on Screening, Intervention and Referral for the Governor’s Prevention Advisory Council. He is the author of A Primer on Adult Children of Alcoholics, Diagnosing and Treating Co-dependence, A Time to Heal, Evaluating and Treating Adult Children of Alcoholics, and A Time To Heal Workbook. His most recent work, Marijuana: What’s a Parent to Believe?, was published by Hazelden in August of 2003.
Bill Manov, PhD - Local Conditions & Initiatives
Dr. Manov has been the Director of the Santa Cruz County Alcohol and Drug Program since 1988. Prior to that he worked for the Los Angeles County Alcohol Program. He is currently responsible for all aspects of publicly funded alcohol and drug prevention, intervention and treatment services in Santa Cruz County. He is a member of the Executive Committee of the County Alcohol and Drug Program Administrators Association of California (CADPAAC), and is Chair of the Fiscal Committee. Dr. Manov holds a doctorate in clinical psychology from the University of Maryland, is certified as a Registered Addictions Specialist, and is formerly licensed as a California Marriage and Family Therapist.
Registration and Cost
Early online registration fee will be $60.00 before Friday, February 15, 2013. Registration fee after this date will be $75.00. The mail-in / fax registration fee is $75.00. Payment must be included at time of registration to reserve a seat.
Click to Register for this Event!!!
Each attendee will be responsible for the local licensing board will accept the AMA PRA Category 1 Credit™ being offered. We strongly recommend that you check with your state regulatory agency to determine whether or not you are eligible for continuing education credit by participating in this educational event.
California Psychologists: This educational activity is recognized by the California Board of Psychology as meeting the continuing education requirements toward license renewal for California psychologists. Psychologists are responsible for reporting their own attendance to the California Board of Psychology.
Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.
California LCSWs and MFTs: Course meets the qualifications for 5 hours of continuing education credit for MFTs, LPCCs, LEPs, and/or LCSWs as required by the California Board of Behavioral Sciences. Provider SCMHSAS / Approval No.PCE 1109.
California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 credit™.
Drug & Alcohol Counselor: Provider is the County of Santa Cruz Health Services Agency, approved for 5 CEH’s (each session) by CAADAC. Provider No. 4S-99-419-0613.
Dominican Hospital, a Dignity Health Member, is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
Dominican Hospital, a Dignity Health Member, designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This credit may also be applied to the CMA Certification in Continuing Medical Education.